Methods for etiologic and early marker investigations in the PLCO trial

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 592, Issue 1-2, 2005, Pages 147-154

  Hayes, Richard B ^a   Sigurdson, Alice ^a   Moore, Lee ^a   Peters, Ulrike ^b   Huang, Wen Yi ^a   Pinsky, Paul ^a   Reding, Douglas ^c   Gelmann, Edward P ^d   Rothman, Nat ^a   Pfeiffer, Ruth M ^a   Hoover, Robert N ^a   Berg, Christine D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MARSHFIELD CLINIC   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cancer; Cohort; Molecular epidemiology

Indexed keywords

BIOLOGICAL MARKER; KU ANTIGEN; TELOMERASE;

BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CELL TRANSFORMATION; CELL VIABILITY; CHROMOSOME ABERRATION; COLORECTAL CANCER; CONFERENCE PAPER; CRYOPRESERVATION; DNA DAMAGE; DNA REPAIR; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LUNG CANCER; METAPHASE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RANDOMIZATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CELL SURVIVAL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 28244472719     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.06.013     Document Type: Conference Paper

References (36)

1. J.K. Gohagan, P.C. Prorok, R.B. Hayes, and B.S. Kramer The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization, and status Contr. Clin. Trials 21 2000 251 272
2. R.B. Hayes, D. Reding, W. Kopp, A.F. Subar, N. Bhat, N. Rothman, N. Caporaso, R.G. Ziegler, C.C. Johnson, J.L. Weissfeld, R.N. Hoover, P. Hartge, C. Palace, and J.K. Gohagan Etiologic and early marker studies in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial Contr. Clin. Trials 21 2000 255 349
3. M.S. Pepe, R. Etzioni, Z.D. Feng, J.D. Potter, M.L. Thompson, M. Thornquist, M. Winget, and Y. Yasui Phases of biomarker development for early detection of cancer J. Natl. Cancer Inst. 93 14 2001 1054 1061
4. D. Clayton, (http://www-gene.cimr.cam.ac.uk/clayton/software/stata ). Accessed Dec, 2004.
5. D.O. Stram, C.A. Haiman, J.N. Hirschhorn, D. Altshuler, L.N. Kolonel, B.E. Henderson, and M.C. Pike Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the multiethnic cohort study Hum. Hered. 55 2003 27 36
6. J.D. Wren, E. Forgacs, J.W. Fondon, A. Pertsemlidis, S.Y. Cheng, T. Gallardo, R.S. Williams, R.V. Shohet, J.D. Minna, and H.R. Garner Repeat polymorphisms within gene regions: phenotypic and evolutionary implications Am. J. Hum. Genet. 67 2000 345 356
7. G.A. Wray, M.W. Hahn, E. Abouheif, J.P. Balhoff, M. Pizer, M.V. Rockman, and L.A. Romano The evolution of transcriptional regulation in eukaryotes Mol. Biol. Evol. 20 2003 1377 1419
8. S. Sturup, R.B. Hayes, and U. Peters Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS Anal. Bioanal. Chem. 38 2005 686 694
9. R.B. Hayes, C.O. Smith, W.Y. Huang, Y. Read, and W.C. Kopp Whole blood cryopreservation in epidemiological studies Cancer Epidemiol. Biomark. Prev. 11 2002 1496 1498
10. S. Bonassi, A. Znaor, H. Norppa, and L. Hagmar Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective Cytogenet. Genome Res. 104 2004 376 382
11. D. Eastmond, and D. Pinnkel Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization and chromosome-specific DNA probes Mut. Res. 234 1990 303 318
12. J.D. Tucker, D.A. Lee, M.J. Ramsey, J. Briner, L. Olsen, and D.H. Moore II On the frequency of chromosome exchanges in a control population measured by chromosome painting Mut. Res. 313 1994 193 202
13. M. Berwick, and P. Vineis Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review J. Natl. Cancer Inst. 92 2000 97 874
14. M.R. Spitz, Q. Wei, Q. Dong, C.I. Amos, and X. Wu Genetic susceptibility to lung cancer: the role of DNA damage and repair Cancer Epidemiol. Biomark. Prev. 12 2003 689 698
15. T. Paz-Elizur, M. Krupsky, S. Blumenstein, D. Elinger, E. Schechtman, and Z. Livneh DNA repair activity of oxidative damage and risk of lung cancer J. Natl. Cancer Inst. 95 2000 1312 1319
16. S. Collue-Duvel, N. Guitton, K. Nourgalieva, F. Legue, J. Leveque, B. Danic, and C. Chenal Alkaline single-scell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer Eur. J. Cancer 40 2004 445 451
17. M.P. Hande, R.V. Azizova, C.R. Geard, L.E. Burak, C.R. Mitchell, V.F. Khokhryakov, E.K. Vasilenko, and D.J. Brenner Am. J. Hum. Genet. 72 2003 1162 1170
18. S.M. Bailey, E.H. Goodwin, J. Mayne, and M.N. Comforth CO-FISH reveals inversions associated with isochromosome formation Mutagenesis 11 1996 39 144
19. E.F. Petricoin, K.C. Zoon, E.C. Kohn, J.C. Barrett, and L.A. Liotta Clinical proteomics: translating benchside promise into bedside reality Nat. Rev. 1 2002 683 695
20. T.P. Conrads, V.A. Fusaro, S. Ross, D. Johann, V. Rajapakse, B.A. Hitt, S.M. Steinberg, E.C. Kohn, D.A. Fishman, G. Whiteley, J.C. Barrett, L.A. Liotta, E.F. Petricoin, and T.D. Veenstra High-resolution serum proteomic features for ovarian cancer detection Endocrine-Relat. Cancer 11 2004 163 178
21. H. Bensmail, J. Golek, M.M. Moody, J.O. Semmes, and A. Haoudi A novel approach for clustering proteomics data using Bayesian fast Fourier transform Bioinformatics 21 10 2005 2210 2224
22. K.A. Baggerly, J.S. Morris, and K.R. Coombes Reproducibility of SELDI TOF protein patterns in serum: comparing datasets from different experiments Bioinformatics 20 5 2004 777 785
23. D.F. Ransohoff Rules of evidence for cancer molecular marker discovery and validation Nat. Rev. Cancer 4 2004 309 313
24. B.L. Wu, T. Abbott, D. Fishman, W. McMurray, G. Mor, K. Stone, D. Ward, K. Williams, and H.Y. Zhao Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data Bioinformatics 19 13 2003 1636 1643
25. G. Izmirlian Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial Ann. N.Y. Acad. Sci. 1020 2004 154 174
26. E. Gorelick, D.P. Landsittel, A.M. Marrangoni, F. Modugno, L. Velikokhatnaya, M.T. Winans, W.L. Bigbee, R.B. Herberman, and A.E. Lokshin Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer CEBP 14 2005 981 987
27. Z. Zhang, R.C. Bast, Y.H. Yu, J.N. Li, L.J. Sokoll, A.J. Rai, J.M. Rosenzweig, B. Cameron, Y.Y. Wang, X.Y. Meng, A. Berchuck, C. van Haaften-Day, N.F. Hacker, H.W.A. de Bruijn, A.G.J. van der Zee, I.J. Jacobs, E.T. Fung, and D.W. Chan Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res. 64 16 2004 5882 5890
28. E.P. Gelmann, D. Chia, and P.F. Pinsky Relationship of demographic and clinical factors to free and total prostate-specific antigen Urology 58 2001 561 566
29. E.D. Crawford, D. Chia, and Andriole PSA changes as related to the initial PSA: data from the prostate, lung, colorectal and ovarian cancer screening trial Proceedings of the American Society of Clinical Oncology Annual Meeting May 2002, Orlando, FL 2002
30. P.F. Pinsky, R.E. Schoen, and J.L. Weissfeld Predictors of advanced proximla neoplasia in persons with abnormal screening flexible sigmoidoscopy Clin. Gastroenterol. Hepatol. 1 2003 103 110
31. R.S. Bresalier, P.F. Pinsky, J.L Weissfeld, et al, Effectiveness of nurse endoscopists in the prostate, lung, colorectal and ovarian cancer screening trial, digestive disease week, San Francisco, CA, 2002.
32. P.F. Pinsky, R.E. Schoen, J.L. Weissfeld, et al., Variability in flexible sigmoidsocopy performance among examiners in a screening trial, Clin. Gastroenterol. Hepatol., in press.
33. P.F. Pinsky, R.E. Schoen, and J.L. Weissfeld Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy Clin. Gastroenterol. Hepatol. 1 2003 103 110
34. R.E. Schoen, P.F. Pinsky, and J.L. Weissfeld Results of repeat sigmoidoscopy 3 years after a negative examination JAMA 290 2003 41 48
35. E.G. McFarland, J.A. Brink, and T.K. Pilgrim Spiral CT colonography: reader agreement and diagnostic performance with two and three dimensional image-display techniques Radiology 218 2001 375 383
36. E.G. McFarland, T.K. Pilgrim, and J.A. Brink CT colonography: multi-observer diagnostic performance Radiology 225 2002 380 390